BUPIVACAINE AGUETTANT 2.5 mg/ml, solution for injection 10 bottles of 20 ml
Active ingredients: Bupivacaine hydrochloride, Bupivacaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection10 bottles of 20 mlinfiltration;intrathécale;péridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BUPIVACAINE AGUETTANT 2,5 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;intrathécale;péridurale;périneurale
- Presentation description
- 10 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- AGUETTANT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Dec 1995
- Prescription and dispensing conditions
- Prescription only, hospital use
- List II: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66563273CIP75651280CIP133400956512805Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUPIVACAÏNE (CHLORHYDRATE DE) MONOHYDRATÉsolution | 2,64 mg · 1 ml | SA |
| CHLORHYDRATE DE BUPIVACAÏNE ANHYDREsolution | 2,50 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.